Gilead Poached Worker To Launch Rival Drug, Vertex Says

Law360, New York (March 28, 2013, 1:14 PM EDT) -- Vertex Pharmaceuticals Inc. slapped rival Gilead Sciences Inc. with a trade secrets lawsuit Wednesday for allegedly poaching a high-level Vertex physician liaison with access to troves of confidential data on its Incivek hepatitis C drug, saying it gives Gilead an unfair advantage as it plans to launch a competing treatment.

The lawsuit targets Gilead and the associate director of Vertex's western region, Betty Kritikos, who has been put on paid leave and is scheduled to start her new job April 1. Gilead has been actively recruiting...
To view the full article, register now.